JOHANNA KAY: Open Payments
NPI 1740476118 · FOLSOM, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$607 in 29 payments from 15 companies in 2025. Trend: 2023 $45 · 2024 $63 · 2025 $607
Food & beverage: $607
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $77 |
| Lilly USA, LLC | 3 | $66 |
| PFIZER INC. | 3 | $62 |
| GlaxoSmithKline, LLC. | 2 | $59 |
| ABBVIE INC. | 2 | $53 |
| Currax Pharmaceuticals LLC | 3 | $47 |
| Alexion Pharmaceuticals, Inc. | 2 | $46 |
| Novo Nordisk Inc | 2 | $46 |
| Abbott Laboratories | 2 | $35 |
| Radius Health, Inc. | 1 | $25 |
Products named: MOUNJARO, AIRSUPRA, CONTRAVE, STRENSIQ, Ozempic, TRELEGY ELLIPTA, AREXVY, PREVNAR 20.
Industry payments across CA — which companies pay providers there.
